Thursday, May 29, 2014
Grand Hyatt New York
109 E 42nd Street
New York, NY 10017
Below is a partial list of the companies that will be presenting.
Acme United Corporation (ACU)
Acme United Corporation is a leading worldwide supplier of innovative cutting, measuring and safety products to the school, home, office, hardware and industrial markets. Its leading brands include Westcott®, Clauss®, Camillus®, PhysiciansCare ® and Pac Kit®. The Company has had five years of increasing sales and earnings, and has been recognized by Forbes, Business Week , and Fortune as among the fastest growing small companies in the U.S.
Advaxis is a clinical-stage biotechnology company developing the next generation of cancer immunotherapies. Advaxis' immunotherapies are based on a novel platform technology using live, attenuated bacteria to stimulate the immune system to selectively target cancer cells while reducing tumor defenses.
Amarantus is a biotechnology company developing treatments and diagnostics for diseases associated with neurodegeneration and protein misfolding-related apoptosis. The Company has licensed Eltoprazine ("Eltoprazine"), a phase 2b ready indication for Parkinson's Levodopa induced dyskinesia and Adult ADHD. The Company has an exclusive worldwide license to the Lymphocyte Proliferation test ("LymPro Test(R)") for Alzheimer's disease and owns the intellectual property rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor ("MANF") and is developing MANF-based products as treatments for brain disorders. Amarantus is a Founding Member of the Coalition for Concussion Treatment (#C4CT), a movement initiated in collaboration with Brewer Sports International seeking to raise awareness of new treatments in development for concussions and nervous-system disorders. The Company also owns intellectual property for the diagnosis of Parkinson's disease ("NuroPro") and the discovery of neurotrophic factors ("PhenoGuard").
APDN is a provider of botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature® DNA describes the uncopyable marker that is at the heart of all of our security and authentication solutions. SigNature® DNA is at the core of a family of products such as SigNature T® for textiles, DNAnet®, our antitheft product, and digitalDNA®, providing powerful track and trace. All provide a forensic chain of evidence and can be used to prosecute perpetrators.
Arch Therapeutics, Inc. (Arch) is a medical device company offering an innovative, elegant, and superior approach to the rapid cessation of bleeding (hemostasis*) and control of fluid leakage (sealant) during surgery and trauma care. The underlying technology, exclusively licensed from a leading university, supports an innovative platform of smart materials that fulfill the criteria as a solution for a specialized field we call, "stasis and barrier applications."
Arch intends to transform the landscape of interventional healthcare with products to seal and protect leaking and bleeding tissue. Arch’s solution elegantly controls the movement of these fluids and substances.
Arch’s products are currently progressing in preclinical development. The first product, AC5 Surgical Hemostatic Device,™ is designed to achieve hemostasis in minimally invasive (laparoscopic**) and open surgical procedures.
AUXILIO is the leading provider of Managed Print Services for Healthcare. A true Management Services company, our focus is to provide turnkey managed print services to our Healthcare clients through situational analysis, strategy development and implementation. We help health systems streamline and align processes and infrastructure to create manageable, dependable print management programs that reduce cost, increase employee productivity and meet and exceed our customers’ patient care standards.
Founded in 2004, AUXILIO serves a national portfolio over 100 health care facilities and manages over 1.6 billion documents annually from over 50,000 devices supporting over 250,000 caregivers. Our business model is vendor neutral and provides full-time, on-site customer service and technical experts at all locations.
BioLargo, Inc. makes life better by delivering technology-based products that help solve some of the world's most important problems that threaten water, food, agriculture, healthcare and energy. The subsidiary BioLargo Water, Inc. showcases the Advanced Oxidation Systems, including its AOS Filter, a product in development specifically designed to eliminate common, troublesome, and dangerous (toxic) contaminants in water in a fraction of the time and cost of current technologies. BioLargo also owns a 50% interest in the Isan System, which was honored with a "Top 50 Water Company for the 21st Century" award by the Artemis Project. The subsidiary Odor-No-More Inc., features award-winning products serving the pet, equine, and consumer markets, including the Nature's Best Solution® and Deodorall® brands. The subsidiary Clyra Medical Technologies, Inc., focuses on advanced wound care management and is preparing to make FDA 510(k) applications in 2014.
Listed on the TSX Venture Exchange (TSXV: RX, OTC Pink: BIOYF) BioSyent is a profitable growth oriented specialty pharmaceutical company which searches the globe to in-license or acquire innovative pharmaceutical products that have been successfully developed, are proven safe and effective, and have track records of improving the lives of patients and supporting the healthcare professionals that treat them.
Black Ridge Oil & Gas is a non-operating exploration and production company in the Bakken and Three Forks play. Black Ridge has participated in drilling over 230 Bakken or Three Forks wells in North Dakota and Montana since 2010. The Company currently controls over 10,000 net Bakken and/or Three Forks acres. Combining experienced management, disciplined operation, low overhead and an aggressive acreage acquisition strategy, Black Ridge is well capitalized and poised to take full advantage of opportunistic mineral leases throughout the Williston Basin.
Blue Calypso, Inc. develops digital innovation products and services for the social media marketplace using its patented IP portfolio. The company enables businesses to employ digital advertising to share and socialize brand content as well as track performance, monitor engagements and gather robust analytics – all at lower costs than traditional marketing. Already, Blue Calypso has attracted a handful of large, well-known consumer facing companies in automotive, retail, travel and consumer goods. Blue Calypso licenses its IP in addition to offering digital innovation services through Blue Calypso Labs and solutions including POPSHARE™, SOCIALECHO™, EMGAGE™ and DashTAGG™.
Calpian, Inc through its subsidiaries, provides an integrated suite of payment processing services and related software enabling products to the U.S. merchant community. It offers credit and debit card processing, ACH, mobile acceptance, and gateway payment solutions to merchants in the U.S. operating in a physical business environment and/or over the Internet, and in settings requiring wired as well as wireless/portable payment solutions.
Calpian subsidiary Money-on-Mobile, a pre-paid mobile payment solutions platform serves approximately 175,000 retail locations in India and has been utilized by over 82 million unique customers. Calpian, Inc. was incorporated in 2006 and is headquartered in Dallas, Texas.
Cardinal Energy Group, Inc. is a U.S producer of oil and natural gas within the United States. The Company is based in Dublin, Ohio. Cardinal focuses on known formations that have significant proven reserves remaining that can be produced economically. Cardinal targets fields with wells that may need remediation due to neglect or undercapitalization. We select prospects that offer a strong up-side for production. The upside we seek in a prospect is twofold – it must have the potential to be restarted or have its current production increased using newer technology and remediation methods and; it must also have additional lease acreage which can be further developed by completing development wells adjacent to existing producing wells. Cardinal exploits these undervalued assets by acquiring a majority working interest in the prospect and then applies the Company’s calculated development plan. Cardinal also seeks acquisitions of over-leveraged companies when there is a clear upside from their purchase based on strong commodity prices. The Company operates throughout the Continental United States.
CEL-SCI is dedicated to research and development directed at improving the treatment of cancer and other diseases by utilizing the immune system, the body's natural defense system. Its lead investigational therapy is Multikine (Leukocyte Interleukin, Injection), currently being studied in a pivotal global Phase III clinical trial. Multikine is the first immunotherapeutic agent being developed as a potential first-line treatment for advanced primary head and neck cancer. CEL-SCI is also investigating an immunotherapy (LEAPS-H1N1-DC) as a possible treatment for H1N1 hospitalized patients and as a vaccine (CEL-2000) for Rheumatoid Arthritis (currently in preclinical testing) using its LEAPS technology platform. The investigational immunotherapy LEAPS-H1N1-DC treatment involves non-changing regions of H1N1 Pandemic Flu, Avian Flu (H5N1), and the Spanish Flu, as CEL-SCI scientists are very concerned about the possible emergence of a new more virulent hybrid virus through the combination of H1N1 and Avian Flu, or maybe Spanish Flu. The Company has operations in Vienna, Virginia, and in/near Baltimore, Maryland.
CounterPath Corporation, is an award-winning provider of SIP-based desktop and mobile VoIP software products and solutions. An industry and user favorite, CounterPath’s Bria softphones for desktop and mobile devices, together with the Company’s server applications and Fixed Mobile Convergence (FMC) solutions, enable service providers, OEMs and enterprises large and small around the globe to offer a seamless and unified communications experience across both fixed and mobile networks. Standards-based, cost-effective and reliable, CounterPath’s award-winning solutions power the voice and video calling, messaging, and presence offerings of customers such as Alcatel-Lucent, AT&T, Avaya, BroadSoft, BT, Cisco Systems, GENBAND, Metaswitch Networks, Mitel, NEC, Network Norway, Rogers and Verizon.
Critical Outcome Technologies Inc. is a leading‐edge technology company specializing in accelerating the discovery and development of small molecules – dramatically reducing the time and cost to bring new drugs to market. COTI’s proprietary artificial intelligence system, CHEMSAS®, utilizes a series of predictive computer models to identify compounds with a high probability of being successfully developed from disease specific drug discovery through chemical optimization and preclinical testing. These compounds are targeted for a variety of diseases, particularly those for which current treatments are either lacking or ineffective.
Cryoport provides end-to-end cryogenic logistics solutions to the life sciences industry through the combination of purpose-built proprietary packaging, information technology and specialized cold chain logistics expertise. Its competencies range from skilled, total turnkey management of the entire life sciences cold chain logistics process to complex total management solutions for outsourced cold chain logistics. Its packaging, built around its Cryoport Express® liquid nitrogen dry vapor shippers, is validated to maintain a constant -150°C temperature for a 10-plus day dynamic shipment duration. Its information technology boast a Cryoportal™ Logistics Management Platform which manages the entire shipment process, including initial order input, document preparation, customs clearance, integrator/courier management, shipment tracking, issue resolution, and delivery. Cryoport uses recyclable and reusable components providing an environmentally friendly solution. Cryoport solutions can record the "chain of condition" and "chain of custody" for shipments thereby meeting the exacting requirements for scientific work and for regulatory purposes.
Customers Bancorp, Inc. is the parent holding company of Customers Bank a community-based, full-service bank headquartered in Phoenixville, Pa., with assets of approximately $4.2 billion. A member of the Federal Reserve System with deposits insured by the Federal Deposit Insurance Corporation ("FDIC"), Customers Bank is an equal housing lender that provides a full range of banking services to small and medium-sized businesses, professionals, individuals and families through offices in Pennsylvania, New York, Rhode Island, Massachusetts and New Jersey. Committed to fostering customer loyalty, Customers Bank uses a High Tech/High Touch strategy that includes use of industry-leading technology to provide customers better access to their money, as well as a continually expanding portfolio of loans to small businesses, multi-family projects, mortgage companies and consumers.
DecisionPoint Systems, Inc. delivers improved productivity and operational advantages to its clients by helping them move their business decision points closer to their customers. They do this by making enterprise software applications accessible to the front-line worker anytime, anywhere. DecisionPoint utilizes all the latest wireless, mobility, and RFID technologies.
DelMar Pharmaceuticals, Inc. was founded in 2010 to develop and commercialize proven cancer therapies in new orphan drug indications where patients are failing modern targeted or biologic treatments. The Company's lead asset, VAL-083, is currently undergoing clinical trials in the United States as a potential treatment for refractory glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer. VAL-083 benefits from extensive clinical research sponsored by the US National Cancer Institute, and is currently approved for the treatment of chronic myelogenous leukemia (CML) and lung cancer in China. Published pre-clinical and clinical data suggest that VAL-083 may be active against a range of tumor types via a novel mechanism of action.
Direct Insite delivers cloud-based e-invoicing solutions for Accounts Payable, Accounts Receivable and Payments automation. Since 2001, Direct Insite has built a track record in automating some of the most demanding financial environments. Today, more than 450,000 suppliers and customers use Direct Insite’s e-invoicing network across over 100 countries (representing more than 35 currencies and 17 languages). Direct Insite’s Invoices On-Line™ platform provides critical procurement, shared services and treasury functionality, which includes: company profile management, e-invoicing, workflow management, payment processing, spend management and business intelligence, dynamic discounting and supply chain financing.
DSS, a leader in anti-counterfeit, authentication, and mass-serialization technologies, provides turnkey security solutions to corporations, governments, and financial institutions around the world. Our custom security programs are designed to protect against product diversion, counterfeit, theft, and other costly and damaging occurrences. From risk analysis and vulnerability assessment, to systems integration and monitoring, DSS offers the advanced tools and knowledge base needed to protect the world's most valuable and at-risk brands.
Dot Hill Systems Corp. designs, manufactures and markets a range of software and hardware storage systems for the entry-level and midrange storage markets. We focus on selling through server-based original equipment manufacturers (OEMs), such as Hewlett-Packard, Dell Inc., Lenovo, Advanced Micro Devices, Inc., and Stratus Technologies; as well as into vertical markets, which primarily include media and entertainment, telecommunications, HPC, Digital Image Archive, Big Data Analytics and oil and gas. Our vertical market customers are OEMs who embed our products into their solutions, as well as resellers.
Founded in 2007, DS Healthcare Group Inc. leads in the development of biotechnology for topical therapies. It has established itself as the world's most effective topical applications for hair-loss. It markets its products online and specialty retailers, distributors, cosmetics wholesalers and in salons in over 10,000 outlets in 20 countries worldwide. Its research has led to a highly innovative portfolio of personal care products and additional innovations in pharmaceutical projects.
Energous is dedicated to developing wireless energy routers for electronic devices such as cell phones, tablets, cameras, lighting, remote controls, games, toys and more. We have developed a wireless power solution that allows a person to roam while charging. The solution is comprised of a transmitter and receiver(s). Unlike inductive pad technologies, our wireless charging allows you the freedom to roam with your devices while they are charged in an energy pocket which moves and tracks with your device.
ESI is a leading supplier of innovative, laser-based manufacturing solutions for the microtechnology industry. Our systems enable precise structuring and testing of micron to submicron features in smart consumer electronics, semiconductors and other high-value components. We partner with our customers to make breakthrough technologies possible in the microelectronics, semiconductor and other emerging industries. Founded in 1944, ESI is headquartered in Portland, Ore., with global operations from the Pacific Northwest to the Pacific Rim.
Full Circle Capital Corporation is a Rye Brook, New York based closed-end investment company that has elected to be treated as a business development company under the Investment Company Act of 1940. Full Circle Capital lends to and invests in senior secured loans and, to a lesser extent, mezzanine loans and equity securities issued by lower middle-market companies that operate in a diverse range of industries. Full Circle Capital’s investment objective is to generate both current income and capital appreciation through debt and equity investments.
Galena Biopharma, Inc. is a Portland, Oregon-based biopharmaceutical company that develops innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care.
Galena's lead product is NeuVax™. NeuVax™ (nelipepimut-S) is the immmunodominant nonapeptide derived from the extracellular domain of the HER2 protein, a well-established target for therapeutic intervention in breast carcinoma. The nelipepimut sequence stimulates specific CD8+ cytotoxic T lymphocytes (CTL) following binding to HLA-A2/A3 molecules on antigen presenting cells (APC). These activated specific CTLs recognize, neutralize and destroy through cell lysis HER2 expressing cancer cells, including occult cancer cells and micrometastatic foci. The nelipepimut immune response can also generate CTLs to other immunogenic peptides through inter- and intra-antigenic epitope spreading. Based on a successful Phase 2 trial, which achieved its primary endpoint of disease-free survival (DFS), the Food and Drug Administration (FDA) granted NeuVax a Special Protocol Assessment (SPA) for its Phase 3 PRESENT (P revention of Recurrence inEarly-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2 Expression with NeuVax Treatment) study. The Phase 3 trial is ongoing and additional information on the study can be found at the recently updated website www.neuvax.com.
According to the National Cancer Institute, over 230,000 women in the U.S. are diagnosed with breast cancer annually. Of these women, only about 25% are HER2 positive (IHC 3+). NeuVax targets approximately 50-60% of HER2-negative patients (IHC 1+/2+ or FISH < 2.2) who achieve remission with current standard of care, but have no available HER2-targeted adjuvant treatment options to maintain their disease-free status.
Founded in its current form in 2012, hopTo Inc. is an innovator of a unique mobile productivity workspace application. hopTo delivers a mobile experience that changes the way you work and live — empowering you to fully embrace a mobile lifestyle – without any compromises or boundaries. Search, Access, Aggregate, Create, Edit and Share your content from your mobile device, efficiently and effectively, by leveraging the power of your own “personal cloud.” The company is based in Campbell, CA.
Implant Sciences is the leader in next generation Explosives Trace Detection (ETD), an established counter-terrorism technology that detects and identifies threats from the small amounts left behind after a person handles explosives. Implant Sciences has sold thousands of units, deployed to over 50 countries worldwide for aviation, public transport, customs, air cargo, critical infrastructure, ports/borders, and emergency response. In January 2013, the Company became only the third ETD manufacturer, and the sole American-owned company, to have product approval from the US Transportation Security Administration. With advanced capabilities including superior sensitivity, inCal™ automatic internal calibration, rapid clear-down, push button maintenance and no radioactive materials, the Company’s handheld QS-H150 and desktop QS-B220 simplify the use, maintenance, and administration of trace detection.
Interlink Electronics is a world-leading trusted advisor and technology partner in the advancing world of human-machine interface and sensor technologies. Interlink Electronics has led the printed electronics industry in its commercialization of its patented Force-Sensing Resistor (FSR®) technology, which has enabled rugged and reliable human-machine interface ("HMI") solutions. For over 29 years, Interlink Electronics' solutions have focused on handheld user input, menu navigation, cursor control, and other intuitive interface technologies for the world's top electronics manufacturers. Interlink Electronics has a proven track record of supplying human-machine interface solutions for mission-critical applications in a wide range of markets, including, but not limited to, consumer electronics, automotive, industrial, and medical devices. Interlink Electronics serves a world-class customer-base from its corporate headquarters in Camarillo, California (greater Los Angeles area), printed-electronics factory in China, global distribution and warehouse facility in Hong Kong, global R&D office in Singapore, global sales office in the United Kingdom, and sales office in Japan.
International Commercial Television, Inc. sells various health, wellness and beauty products through infomercials and other channels primarily in the United States. ICTV utilizes a distinctive marketing strategy and multi-channel distribution model to develop, market and sell products through infomercials, live home shopping television, specialty outlets and online shopping. It offers health and beauty products, including DermaWand, a skin care device that reduces the appearance of fine lines and wrinkles, and helps improves skin tone and texture; and DermaVitál, a professional quality skin care range that effects superior hydration. International Commercial Television Inc. was founded in 1993 and headquartered in Wayne, Pennsylvania.
Iveda is a premier cloud video hosting service provider, a technology innovator, and a provider of enterprise-class Video Surveillance as a Service (“VSaaS”) solutions. The Company has a SAFETY Act Designation from the Department of Homeland Security as a Qualified Anti-Terrorism Technology Provider. Iveda is headquartered in Mesa, Arizona and has a subsidiary in Taiwan (MEGAsys).
Keating Capital is a closed-end fund (regulated as a business development company under the Investment Company Act of 1940) that specializes in making pre-IPO investments in emerging growth companies that are committed to and capable of becoming public. Keating Capital provides investors with the ability to participate in a publicly traded fund that allows its stockholders to share in the potential value accretion that Keating Capital believes typically occurs once a company transforms from private to public status.
Lightlake Therapeutics Inc., a biopharmaceutical company, develops treatments for common addictions and related disorders. Lightlake currently is developing an intranasal naloxone treatment to reverse opioid overdoses. Lightlake has collaborated with the Division of Pharmacotherapies and Medical Consequences of Drug Abuse of NIDA, part of the NIH, to develop this treatment. Lightlake also is focused on developing treatments in other areas, including for patients with Binge Eating Disorder, Bulimia Nervosa, and opioid drug addiction.
Local Corporation, a leading local advertising and technology company, serves publishers, advertisers, retailers and developers through a variety of innovative digital advertising products. Local connects businesses with millions of online and mobile consumers through its consumer search business. The company is driving growth by expanding its network products with new display, pay-per-click, mobile search and pay-per-call ad formats, and by monetizing its patented local shopping and discovery platform Krillion®. This platform aggregates, normalizes and distributes dynamic, national and regional retail shopping content from ~120,000 store locations, representing nearly 3 million localized products. Local’s intellectual property represents another valuable monetization opportunity.
Max Sound Corporation is the creator of the audio process that brings high definition (HD) sound to all digital media. MAX-D is the technology that dramatically improves sound quality by resynthesizing and restoring the lost, compressed sound harmonics, while preserving the smallest possible file size. MAX-D HD is hardware/platform neutral – no need to change equipment or infrastructure. With over 70 patents pending, MAX-D makes any system sound better. Recent Initiatives: Qualcomm Snap Dragon Processor & Hexagon program. MAX-D HD Audio technology is now embedded on the DSP (Digital Signal Processor) and available for licensing to the 86 Qualcomm OEM's. Qualcomm has taken the lead and is now directly marketing MAX-D HD Audio to its customers. As part of MAXD’s ‘Go To Market’ strategy, it is targeting Music and Mobile. Via its Liquid Spins subsidiary (and the partnership with InComm, a leading billion dollar industry leader of prepaid cards) it is expanding its prepaid music gift cards initiative. MAXD has also recently begun to target the automobile manufactures to adopt MAX-D HD audio in vehicles (15 million autos sold last year).
Medient Studios, Inc. is an entertainment content creation company with a strong presence in North America, Europe and India. Medient's management team has approximately 150 years of experience in the motion picture industry and is responsible for producing and/or financing over 250 movies. Medient is realigning the content creation process to enable efficiencies of scale and eliminate process waste by building a fully integrated movie and electronic game production facility as part of its Studioplex on a 1,550-acre property in Effingham County, Georgia. Once operational this production facility will be the largest of its kind in the United States.
MVC Capital, Inc. ("MVC") is a business development company traded on the New York Stock Exchange, under the listing symbol MVC and is advised by The Tokarz Group Advisers LLC ("TTG Advisers").
MVC provides long-term equity and debt investment capital to fund growth, acquisitions and recapitalizations of small and middle-market companies in a variety of industries primarily located in the U.S. MVC's investments can take the form of common and preferred stock (control and non-control investments) and warrants or rights to acquire equity interests; senior and subordinated loans; or convertible securities. MVC serves as the lead investor for transactions, as well as a co-investor in companies along with other private equity sponsors.
NanoViricides, Inc., in a pre-clinical biotech company developing anti-viral drugs to destroy a wide range of viruses in and on the body as well as in the eye. The Company has developed a platform technology, based on the principles of nanotechnology, that enables rapid drug development either in the lab or in the field.
The Company has successfully treated 5000 animals after infection with a wide range of viral diseases. These include all forms of influenza, HIV/AIDS, herpes of the genitals and the eye, adenovirus of the eye, dengue and dengue hemorrhagic fever, rabies and Ebola.
Construction of a new facility and pilot production plant is currently underway and human trials for our influenza cure are now planned for the second half of 2014.
The Company is well funded and currently actively trades on the OTCBB with a market cap of $120M.
NeoStem, Inc. is a leader in the emerging cellular therapy industry. The Company’s business model includes the development of novel proprietary cell therapy products as well as operating a contract development and manufacturing organization providing services to others in the regenerative medicine industry. The combination of a therapeutic development business and revenue-generating service provider business provides the Company with capabilities for cost effective in-house product development and immediate revenue and cash flow generation.
Established in 1999, NetDimensions (AIM: NETD; OTCQX: NETDY) is a global provider of performance, knowledge, and learning solutions. NetDimensions provides companies, government agencies and other organizations with talent management solutions to personalize learning, share knowledge, enhance performance, foster collaboration, and manage compliance programs for employees, customers, partners and suppliers. Recognized as one of the talent management industry's top-rated technology suppliers in overall customer satisfaction, NetDimensions has been chosen by leading organizations worldwide including ING, Cathay Pacific, Hunter Douglas, Chicago Police Department, Geely Automotive, Fugro Group, and Fresenius Medical Care. NetDimensions is ISO 9001 certified and NetDimensions hosted services are ISO 27001 certified.
NXT-ID, Inc. is a next generation biometric authentication company. Their innovative MobileBio™ solutions mitigate consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching our innovative suite of biometric and encryption solutions that secure consumers’ mobile and online platforms.
Oculus Innovative Science is the global anti-antibiotic healthcare company that designs, manufactures and markets prescription and non-prescription products in 33 countries. The company's products are used to treat patients in surgical/advanced wound management, dermatology, women’s health and animal health; addressing the unmet medical needs of these markets—while raising the standard of patient care and lowering overall healthcare costs. The company's headquarters are in Petaluma, California, with manufacturing operations in the United States and Latin America. More information can be found at www.oculusis.com.
OncoSec Medical Incorporated is a biopharmaceutical company developing its advanced-stage ImmunoPulse DNA-based immunotherapy therapy to treat solid tumor cancers. OncoSec’s treatment aims to harness the body’s immune system to target and kill cancer cells and consists of using its proprietary electroporation platform to enhance the uptake of a locally delivered DNA-based immunocytokine.
Pressure BioSciences, Inc. ("PBI") is a life sciences tools company focused on the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables based on our game-changing Pressure Cycling Technology ("PCT"). PCT is a patented, enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels (58,000 psi or greater) to safely, conveniently and reproducibly control the actions of molecules in biological samples, such as cells and tissues from human, animal, plant, and microbial sources. We currently focus the majority of our efforts on the development and sale of PCT-enhanced systems (instruments and consumables) to address the challenging problems inherent in biological sample preparation, a crucial laboratory step performed by tens of thousands of scientists worldwide working in biological life sciences research. Through 2013, we have over 250 PCT Systems in leading academic, government, biotech, and pharma companies worldwide. Primary PCT uses currently include biomarker discovery and forensics.
PCT advantages include: (a) extraction and recovery of more membrane proteins, (b) enhanced protein digestion, (c) differential lysis in a mixed sample base, (d) pathogen inactivation, (e) increased DNA detection, and (f) exquisite sample preparation process control.
PURE Bioscience is focused on developing and commercializing our proprietary antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control. Led by a new management team, PURE has already made significant progress – focusing on commercialization in the food safety arena -- a $2 billion market. Our patented technology platform is based on patented stabilized ionic silver, and our initial products contain silver dihydrogen citrate, or SDC. SDC is a broad-spectrum, non-toxic antimicrobial agent, which offers 24-hour residual protection and formulates well with other compounds. SDC-based disinfecting and sanitizing products are registered by the EPA. SDC is distinguished from competitors in the marketplace because of its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it. PURE is headquartered in El Cajon, California (San Diego metropolitan area).
RiceBran Technologies is a human food ingredient and animal nutrition company focused on the procurement, bio-refining and marketing of numerous products derived from rice bran. Rice Bran Technologies has proprietary and patented intellectual property that allows us to convert rice bran, one of the world's most underutilized food sources, into a number of highly nutritious human food ingredient and animal nutrition products. Our target markets are human food ingredients and animal nutrition manufacturers and retailers, as well as natural food, functional food and nutraceutical supplement manufacturers and retailers, both domestically and internationally.
Rocky Mountain Chocolate Factory, Inc. (RMCF) incorporated in 1982 and is headquartered in Durango, Colorado. The Company is an international franchisor of gourmet chocolate and confection stores and manufacturer of an extensive line of premium chocolates and other confectionery products. The Company's revenues are derived from three principal sources: sales to franchisees and others of chocolates and other confectionery products manufactured by the Company; the collection of initial franchise fees and royalties from franchisees' sales; and sales at Company-owned stores of chocolates and other confectionery products.
The Company’s majority-owned subsidiary, U-Swirl, Inc. (SWRL), is a franchisor and operator of self-serve frozen yogurt stores. The Company, its subsidiary and its franchisees operates approximately 425 Rocky Mountain Chocolate Factory and U-Swirl self-serve frozen yogurt stores in 42 states, Canada, Japan and the United Arab Emirates.
Headquartered in Livingston, New Jersey, SilverSun Technologies, Inc. provides best of breed technology and software solutions to small and medium size businesses (SMBs) in the manufacturing, distribution and service industries. For the first 9 months of 2013, the Company reported sales of $12,290,088, and net income of $95,496. In 2012, the Company generated annual revenues totaling approximately $13.2 million. The Company’s third quarter 2013 revenues rose 26%, making it the eighth consecutive quarter of double digit percentage revenue growth. Moving forward, SilverSun is intent on accelerating its growth with a goal of ramping sales five-fold to $50+ million within the next four years.
SilverSun is executing a growth strategy centered on the acquisition of cloud technology providers and software publishers of unique and proprietary solutions in the extensive and expanding business solutions marketplace. In addition, the Company focuses on the design and development of its own proprietary cloud-based, SAAS business management solutions. To date, SilverSun has acquired SWK Technologies, Inc. (its principal operating subsidiary); Business Tech Solutions Group, Inc.; Wolen Katz Associates; AMP-BEST Consulting, Inc.; IncorTech; Micro-Point, Inc.; HighTower, Inc.; Point Solutions, LLC; and SGEN, LLC.
Sino-Global Shipping America, Ltd. (Sino-Global) is a Virginia corporation with primary US operations in New York and subsidiaries in mainland China, Hong Kong, Australia and Canada. We provide our customers with comprehensive yet customized shipping agency, shipping and chartering, and inland transportation management services. As a general shipping agent, Sino-Global serve ships coming to and departing from a number of countries and regions, including China, Australia, South Africa, Brazil, Hong Kong, Canada and the US.
SMTP is a provider of services to facilitate email delivery, with a focus on marketing email delivery, but also supporting bulk and transactional sending, reputation management, compliance auditing, abuse processing and issue resolution. Our services provide customers with the ability to increase the deliverability of email with less time, cost and complexity than handling it themselves. SMTP, Inc. is a dividend-paying, publicly-traded company headquartered in Nashua, NH.
Snap Interactive, Inc. (“SNAP”) develops, owns and operates a social dating application for social networking websites and mobile platforms. SNAP’s flagship brand, AYI.com, is one of the largest social dating applications on the Internet with over 70 million installs, including over 25 million Facebook connected singles. By connecting singles through shared interests and mutual friends, AYI.com enhances the dating experience and creates smarter, more meaningful matches.
Soligenix, Inc. is a clinical stage biopharmaceutical company committed to developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. Soligenix has two areas of focus: 1) a therapeutics segment dedicated to the development of products for orphan diseases and areas of unmet medical need such as oral mucositis, pediatric Crohn's disease, acute radiation enteritis, and Graft-versus-Host disease (GVHD), and 2) a vaccines/biodefense segment to develop vaccines and therapeutics for military and civilian applications in the areas of ricin exposure, anthrax exposure, gastrointestinal acute radiation syndrome, and melioidosis.
Sono-Tek Corporation offers a broad portfolio of ultrasonic atomization-based spray coating products for the Electronics, Advanced Energy, Medical Device, Glass, Textile, and Food Industries. Sono-Tek has two primary operating units (SBUs): Electronics & Advanced Energy (EAE) and Ultrasonic Coating Solutions (UCS):
Electronics & Advanced Energy (EAE)
The EAE strategic business unit saw a decrease of 20% in sales in FY2013 compared to FY2012, mainly due to a decrease in government spending for advanced energy research. It provided spray fluxers for manufacture of printed circuit boards, and special ultrasonic spray coaters for the manufacture of semiconductors (MEMs), PV and thin film solar cells, Fuel Cells, touch screen displays and OLEDs.
Ultrasonic Coating Solutions (UCS)
The UCS business unit saw a decrease of 21% in sales FY2013 compared to FY2012. It provided ultrasonic spray coating systems to the medical device industry (stents, bandages, implantables, and diagnostic devices), as well as WideTrack coaters for the manufacture of float glass, and for spray coating of textiles with functional chemicals such as flame retardants, moisture repellents, and anti-bacterial agents. UCS provided the food industry with equipment for direct food contact coating of flavorings, anti-microbial agents, oils, and moisture barrier compounds.
Stellar Biotechnologies, Inc. (OTCQB: SBOTF) (TSX-V: KLH) is a commercialization stage company focused in the immunotherapy arena, with world-leading technology in Keyhole Limpet Hemocyanin (KLH) protein. KLH is an important immune-stimulating molecule widely used as a key active ingredient in many new immunotherapies, and as an injectable product to assess immune response. We are committed to applying our Stellar KLH™ platform to power the growing field of disease-targeting immune therapies.
Straight Path Communications Inc. (NYSE MKT: STRP) is the largest holder of 39 GHz spectrum in the United States through its Straight Path Spectrum subsidiary. Straight Path holds nearly 70% of FCC licensed 39 GHz spectrum, covering all 50 states with exceptionally deep coverage in the top 80 metros. Straight Path leases its 39 GHz spectrum as a high quality alternative to running fiber for telco networks and last mile enterprise applications. Straight Path's 39 Spectrum provides an excellent solution for mobile network operators for nationwide small cell deployment in cities.
The Company's Straight Path IP Group subsidiary holds and licenses its intellectual property for efficient communications over the Internet.
Sutor is one of the leading China-based manufacturers and distributors of high-end fine finished steel products used by a variety of downstream applications. The Company utilizes a variety of in-house developed processes and technologies to convert steel manufactured by third parties into fine finished steel products, including hot-dip galvanized steel, pre-painted galvanized steel, acid-pickled steel, cold-rolled steel and welded steel pipe products.
Sysorex Global Holdings Corp. is a leading provider of Information Technology Support Services for enterprise level IT environments including full life cycle software development, interface, integration, operational support, and IT Network Infrastructure Modernization Services. With over 30 years of operating history, they provide a wide range of consulting, systems engineering, cyber security, data analytics and program management expertise.
Targeted Medical Pharma is a Los Angeles-based biotechnology company that develops prescription medical foods for the treatment of chronic disease, including pain syndromes, peripheral neuropathy, hypertension, obesity, sleep and cognitive disorders. The company manufactures 10 proprietary prescription-only medical foods. These prescription medical foods and therapeutic systems are sold to physicians and pharmacies in the United States through the company€s subsidiary, Physician Therapeutics. These proprietary medications represent a novel approach to the management of certain disease states, focusing on safety and efficacy without the deleterious side effects of traditional, high dose prescription drugs. The company is developing nutrient-based systems for oral stimulation of progenitor stem cells that differentiate into neurons, red blood cells, pituitary hormones including IGF-I.
Tauriga Sciences, Inc. (TAUG) is a diversified company focused on generating profitable revenues through license agreements and the development of a proprietary technology platform in the nano-robotics space. The mission of the Company is to acquire and build a diversified portfolio of cutting edge technology assets that is capital efficient and of significant value to the shareholders. The Company's business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses. Management is firmly committed to building lasting shareholder value in the short, intermediate, and long terms. On January 28, 2014 the Company completed its acquisition of Cincinnati, Ohio based Pilus Energy LLC ("Pilus Energy"), a developer of alternative cleantech energy platforms using proprietary microbial solutions that creates electricity while consuming polluting molecules from wastewater. The Company entered into a definitive merger agreement on March 11, 2014 with Oakland, California based Honeywood LLC which develops topical medicinal cannabis lotions.
Taxus Cardium Pharmaceuticals Group Inc. (formerly Cardium Therapeutics) is an advanced regenerative therapeutics company that is focused on the late-stage clinical and commercial development of regenerative medicine therapeutics including Generx®, an interventional cardiology, angiogenic gene therapy product candidate designed for the treatment of patients with cardiac microvascular insufficiency with myocardial ischemia due to advanced coronary artery disease, and Excellagen®, an FDA-cleared acellular biological skin substitute designed as a professional-use advanced wound care product for the treatment of chronic non-healing diabetic foot, venous and pressure ulcers, which also has multiple additional potential tissue regeneration applications based on stem cells and other biologics.
Torchlight Energy Resources, Inc., based in Plano, Texas, is a high growth oil and gas Exploration and Production (E&P) company with a primary focus on acquisition and development of highly profitable domestic oil fields. The company currently holds interests in Texas, Kansas and Oklahoma where their targets are established plays such as the Eagle Ford, Mississippian and Hunton trends.
Towerstream is a leading 4G and Small Cell Rooftop Tower company. The company owns, operates, and leases Wi-Fi and Small Cell rooftop tower locations to cellular phone operators, tower, Internet and cable companies and hosts a variety of customers on its network. Towerstream was originally founded in 2000 to deliver fixed-wireless high-speed Internet access to businesses and to date offers broadband services in over 12 urban markets including New York City, Boston, Los Angeles, Chicago, Philadelphia, the San Francisco Bay area, Miami, Seattle, Dallas-Fort Worth, Houston, Las Vegas-Reno, and the greater Providence area. For more information on Towerstream services, please visit www.towerstream.com and/or follow us @Towerstream on Twitter. In 2013, Towerstream Corporation, formed HetNets Tower Corporation (“HetNets”), a wholly owned subsidiary, to offer a neutral host network solution enabling wireless carriers, cable and Internet companies to expand their network footprint and increase coverage and capacity to their platforms.
U.S. Geothermal is a renewable energy company focused on developing, owning, and operating clean, sustainable electric power from geothermal energy resources, while continually striving to create enhanced value for our shareholders and promoting a clean environment. The company is currently producing about 45MW from geothermal power projects at Neal Hot Springs, Oregon, San Emidio, Nevada and Raft River, Idaho.
Headquartered in Charlotte, North Carolina and serving over 200,000 businesses across North America, the United Kingdom and Australia, UBL Interactive is the owner and operator of the Universal Business Listing (UBL) service. Through UBL, the Company provides business identity management tools for businesses large and small, as well as SEO providers, advertising agencies and interactive marketers to help their customers distribute their business details as a trusted source across search engines, online Yellow Pages directories, 411 directory assistance, social networks and mobile devices. The Company also offers reputation monitoring tools and a variety of premium Local SEO optimization services. For more information please visit: http://www.ublinteractive.com
uSell.com is a reCommerce marketplace that helps individuals turn unused items into cash. uSell ensures that customers get the highest payouts with the least amount of hassle by facilitating risk-free transactions with professional buyers. For uSell’s buyers, uSell offers a scalable technology, marketing, logistics, and analytics solution that provides a high volume of inventory at a low acquisition cost.
We design, market, and distribute electronic cigarettes, vaporizers, e-liquids and accessories under the Krave®, Fifty-One® (also known as Smoke 51), VaporX®, Hookah Stix®, Alternacig®, EZ Smoker®, Green Puffer®, Americig®, Fumaré™ and Smoke Star® brands. We also design and develop private label brands for our distribution customers. Our products are manufactured to meet our design specifications. We market our electronic cigarettes as an alternative to traditional tobacco cigarettes. “Electronic cigarettes” or “e-cigarettes,” look like traditional cigarettes and are battery-powered products that enable users to inhale nicotine vapor without smoke, tar, ash, or carbon monoxide. Our shares of common stock are currently quoted on the OTC Bulletin Board under the symbol VPCO.OB.
Verastem is a biopharmaceutical company focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells. A cancer stem cell is a particularly aggressive type of tumor cell, resistant to conventional cancer therapy, that we believe is an underlying cause of tumors, their recurrence and metastasis. We have proprietary technology licensed from our scientific founders at the Whitehead and Broad Institutes of MIT/Harvard to create a stable population of cancer stem cells that we use to screen for and identify small molecule compounds that target cancer stem cells.
Our most advanced programs target the Focal Adhesion Kinase, or FAK, and the PI3K/mTOR signaling pathways. Our lead FAK inhibitor, VS-6063 or defactinib, has orphan drug designation for use in mesothelioma in the European Union and in the United States. VS-6063 is currently undergoing clinical trials in 12 countries worldwide. VS-6063 is being evaluated in a registration-directed trial (COMMAND) in patients with mesothelioma which has the potential to lead to regulatory approval in late 2016/early 2017. In addition, VS-6063 is in a Phase 1b trial in combination with weekly paclitaxel for patients with ovarian cancer, a Phase 2 study in patients with non-small cell lung cancer and a Phase 1 trial in Japan in patients with solid tumors. In addition to VS-6063, both our FAK inhibitor VS-4718 and our dual mTORC1/2 and PI3K inhibitor VS-5584 are in Phase 1 clinical trials in patients with advanced cancers.
We are a publicly-traded company listed on NASDAQ under the ticker symbol ‘VSTM’. We had $123.7 million as of 12/31/13 which we expect to fund operations into 2016 based on current development plans. Our headquarters are located at 215 First Street in Cambridge, Massachusetts.
VolitionRx is a life sciences company focused on developing blood-based diagnostic tests for different types of cancer. The tests are based on the science of Nucleosomics which is the practice of identifying and measuring nucleosomes in the bloodstream – an indication that cancer is present.
VolitionRx’s goal is to make the tests as common and simple to use, for both patients and doctors, as existing diabetic and cholesterol blood tests. VolitionRx’s research and development activities are currently centered in Belgium as the company focuses on bringing its diagnostic products to market first in Europe, then in the US and ultimately, worldwide.